These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37304539)

  • 1. Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy.
    Chen ZD; Luo JY; Ye YP; Dang YW
    Transl Cancer Res; 2023 May; 12(5):1210-1231. PubMed ID: 37304539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma.
    Xiao J; Liu T; Liu Z; Xiao C; Du J; Zuo S; Li H; Gu H
    Cells; 2022 Jul; 11(15):. PubMed ID: 35892599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential biomarkers for the prognosis and treatment of HCC immunotherapy.
    Li H; He Q; Zhou GM; Wang WJ; Shi PP; Wang ZH
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2027-2046. PubMed ID: 36930502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.
    Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma.
    Liu L; Liu Z; Gao J; Liu X; Weng S; Guo C; Hu B; Wang Z; Zhang J; Shi J; Guo W; Zhang S
    Front Immunol; 2022; 13():964190. PubMed ID: 35967384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
    Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
    BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
    Chen J; Chen X; Li T; Wang L; Lin G
    Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing.
    Chen W; Zhang F; Xu H; Hou X; Tang D; Dai Y
    Pathol Oncol Res; 2022; 28():1610199. PubMed ID: 36091935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
    Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
    Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell infiltration and immunotherapy in hepatocellular carcinoma.
    Jiang Y; Lin L; Lv H; Zhang H; Jiang L; Ma F; Wang Q; Ma X; Yu S
    Math Biosci Eng; 2022 May; 19(7):7178-7200. PubMed ID: 35730302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
    Gao B; Wang Y; Li C; Lu S
    Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Immune-Related Markers in Hepatocellular Carcinoma Based on Gene Co-expression Network.
    Li G; Tian Y; Gao Z; Ma X; Ren C
    Biochem Genet; 2022 Dec; 60(6):2552-2569. PubMed ID: 35633444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma.
    Yu X; Chen P; Yi W; Ruan W; Xiong X
    Front Immunol; 2022; 13():1029872. PubMed ID: 36275676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.
    Wang H; Fu Y; Da BB; Xiong G
    J Healthc Eng; 2022; 2022():8256314. PubMed ID: 35449866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    He Z; Peng C; Li T; Li J
    Front Genet; 2022; 13():858905. PubMed ID: 35360852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients.
    Qiu J; Wang H; Lv X; Mao L; Huang J; Hao T; Li J; Qi S; Chen G; Jiang H
    Open Life Sci; 2023; 18(1):20220656. PubMed ID: 37589009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.